{
    "clinical_study": {
        "@rank": "51792", 
        "arm_group": [
            {
                "arm_group_label": "Case Group", 
                "description": "Patients with chronic kidney disease of stage 3-4."
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "30 healthy subject"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to evaluate whether a low level of serum omentin-1 is associated\n      with carotid atherosclerosis and mediated by inflammation."
        }, 
        "brief_title": "Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Non-diabetic Chronic Kidney Disease", 
            "Atherosclerosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic", 
                "Carotid Artery Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Atherosclerotic cardiovascular disease is markedly increased in chronic kidney disease.\n      There are a lot of risk factor, along with conventional risk factors. Serum onemtin-1 is a\n      adipokine and suggested as a new marker for vascular disease.It has some anti-atherogenic\n      properties. Studies investigating serum omentin-1 level have usually conducted in patients\n      with diabetes mellitus."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  between ages of 18 - 65 years old chronic kidney disease of stage 3-4\n\n        Exclusion Criteria:\n\n          -  Chronic kidney disease of stage 5\n\n          -  The history of ischemic cardiovascular disease (myocardial infarction, unstable\n             angina, stroke, peripheral artery disease, or cardiovascular revascularization)\n\n          -  Severe heart failure\n\n          -  Stage 2 hypertension\n\n          -  Diabetes mellitus\n\n          -  Corticosteroid therapy\n\n          -  Severe hepatic disease\n\n          -  Smoking\n\n          -  Inflammatory disease\n\n          -  Acute infectious disease\n\n          -  Malignancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Department of Nephrology, Check-up clinic"
            }
        }, 
        "enrollment": {
            "#text": "85", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01701830", 
            "org_study_id": "2012/02"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "omentin-1", 
            "carotid atherosclerosis", 
            "kidney disease"
        ], 
        "lastchanged_date": "October 4, 2012", 
        "location": {
            "contact": {
                "email": "drrabia1@yahoo.com", 
                "last_name": "Rabia TERZI, MD", 
                "phone": "90262 317 80 00", 
                "phone_ext": "8110"
            }, 
            "facility": {
                "address": {
                    "city": "Izmit", 
                    "country": "Turkey", 
                    "state": "Kocaeli", 
                    "zip": "41100"
                }, 
                "name": "Department of Nephrology, Check-up Clinic,Kocaeli Derince Education and Traning Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Erkan SENGUL, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gokhan DUYGULU, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sevim DINDAR, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fatih BUNUL, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Relationship Between Serum Omentin-1 and IL-6 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease", 
        "overall_official": {
            "affiliation": "Kocaeli Derince Education and Training Hospital", 
            "last_name": "Erkan SENGUL, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01701830"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Kocaeli Derince Education and Research Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kocaeli Derince Education and Research Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}